Olaquindox metabolite(MQCA) antibody/antigen (BSA/OVA/KLH conjugated hapten)

anti-Olaquindox metabolite(MQCA) antibody and Carrier-coupled antigen/immunogen (hapten-carrier conjugates)

Target products collectionGo to food safety diagnostics products collection >>


Product information

Catalog No.DescriptionUS $ Price (per mg)
GMP-SMT-143-11. BSA-Olaquindox metabolite(MQCA)
2. Anti-Olaquindox metabolite(MQCA) mouse monoclonal antibody
$2709.00
GMP-SMT-143-21. OVA-Olaquindox metabolite(MQCA)
2. Anti-Olaquindox metabolite(MQCA) mouse monoclonal antibody
$2709.00
GMP-SMT-143-31. BSA-Olaquindox metabolite(MQCA)
2. Anti-Olaquindox metabolite(MQCA) human monoclonal antibody
$2709.00
GMP-SMT-143-41. OVA-Olaquindox metabolite(MQCA)
2. Anti-Olaquindox metabolite(MQCA) human monoclonal antibody
$2709.00
GMP-SMT-143-Ag-1BSA-Olaquindox metabolite(MQCA)$756.00
GMP-SMT-143-Ag-2OVA-Olaquindox metabolite(MQCA)$756.00
GMP-SMT-143-Ab-1Anti-Olaquindox metabolite(MQCA) mouse monoclonal antibody$1953.00
GMP-SMT-143-Ab-2Anti-Olaquindox metabolite(MQCA) human monoclonal antibody$1953.00

Size: 1mg | 10mg | 100mg



Product Description


BSA-Olaquindox metabolite(MQCA)

Cat No.GMP-SMT-143-Ag-1
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Products descriptionCompetitive immunoassay-validated hapten-carrier conjugates BSA-Olaquindox metabolite(MQCA) with anti-Hapten antibody. The hapten hapten-carrier conjugates BSA-Olaquindox metabolite(MQCA) had been validated with our anti-Hapten antibody Anti-Olaquindox metabolite(MQCA) mouse monoclonal antibody via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
Formulation & ReconstitutionLyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


OVA-Olaquindox metabolite(MQCA)

Cat No.GMP-SMT-143-Ag-2
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Products descriptionCompetitive immunoassay-validated hapten-carrier conjugates OVA-Olaquindox metabolite(MQCA) with anti-Hapten antibody. The hapten hapten-carrier conjugates OVA-Olaquindox metabolite(MQCA) had been validated with our anti-Hapten antibody Anti-Olaquindox metabolite(MQCA) mouse monoclonal antibody via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
Formulation & ReconstitutionLyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Anti-Olaquindox metabolite(MQCA) mouse monoclonal antibody

Cat No.GMP-SMT-143-Ab-1
Host of AntibodyMouse IgG
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Lateral flow immunoassay (LFIA);
ELISA IC50 (ppb)1-2
Products descriptionThe anti-Hapten antibody against hapten Olaquindox metabolite(MQCA) had been validated with our hapten hapten-carrier conjugates BSA-Olaquindox metabolite(MQCA) via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
Formulation & ReconstitutionLyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Anti-Olaquindox metabolite(MQCA) human monoclonal antibody

Cat No.GMP-SMT-143-Ab-2
Host of AntibodyHuman IgG1
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Lateral flow immunoassay (LFIA);
ELISA IC50 (ppb)1-2
Products descriptionThe anti-Hapten antibody against hapten Olaquindox metabolite(MQCA) had been validated with our hapten hapten-carrier conjugates BSA-Olaquindox metabolite(MQCA) via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
Formulation & ReconstitutionLyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Biomarker Information


    1. Olaquindox Metabolite (MQCA) in Veterinary Drug Residues and Additives

    1.1 Definition and Role

    Olaquindox Metabolite (MQCA) is a crucial small molecule compound formed as a result of metabolic processes involving Olaquindox, a veterinary antibiotic and growth-promoting agent extensively employed in the realm of animal husbandry. Its role holds significant importance in the context of veterinary drug residues and additives, particularly due to its involvement in various aspects of animal farming and food safety.

    1.2 Veterinary Application and Residue Concerns

    Olaquindox has been a staple in animal farming practices, revered for its capacity to enhance livestock growth rates and optimize feed efficiency. However, concerns have emerged regarding the potential persistence of Olaquindox residues in animal tissues and animal-derived food products, including meat and dairy items. MQCA emerges as a pivotal metabolite formed during the metabolic transformation of Olaquindox within animals. As such, it is deeply entwined with the dynamics of Olaquindox usage in the agricultural sector.

    The presence of MQCA in animal tissues and food products carries profound regulatory and public health implications. It operates as a definitive marker, signaling the residual presence of Olaquindox and the extent of its impact. Therefore, the quantification and monitoring of MQCA levels are imperative for ensuring the responsible administration of Olaquindox and safeguarding both animal and human health.

    2. Significance of Measuring Olaquindox Metabolite (MQCA)

    2.1 Residue Detection and Regulatory Compliance

    The measurement of Olaquindox Metabolite (MQCA) is pivotal for several compelling reasons, each contributing to the intricate landscape of veterinary drug residues and regulatory adherence:

    a. Residue Detection: MQCA serves as an indispensable biomarker in the identification and quantification of Olaquindox residues within animal tissues and food products. This analytical approach underpins rigorous surveillance, regulatory compliance, and the enforcement of established guidelines governing Olaquindox utilization in animal agriculture.

    b. Food Safety Assurance: The paramount concern is ensuring the safety of food products derived from animals. The measurement of MQCA plays an instrumental role in identifying and mitigating potential Olaquindox contamination, thereby safeguarding consumers against inadvertent exposure to harmful residues that may manifest adverse health consequences.

    c. Regulatory Adherence: Veterinary drug residues, including Olaquindox and its metabolites like MQCA, are subject to stringent regulatory limits and constraints across numerous jurisdictions. The routine measurement of MQCA is pivotal in guaranteeing strict compliance with these regulations, thereby averting legal consequences associated with violations.

    d. Promoting Ethical Practices: Beyond regulatory aspects, the quantification of MQCA contributes to the broader objective of promoting ethical practices within the animal agriculture industry. By facilitating precise measurements, it curbs the propensity for excessive Olaquindox use, thereby fostering sustainability, animal welfare, and responsible agricultural practices.

    e. Scientific Insight: In the realm of scientific inquiry, the measurement of MQCA provides profound insights into the pharmacokinetics and metabolism of Olaquindox within animals. This knowledge is invaluable for researchers seeking to develop alternative veterinary drugs that are safer, more efficacious, and less prone to residue-related concerns.

    In summation, the measurement of Olaquindox Metabolite (MQCA) transcends the realm of analytical chemistry; it assumes paramount significance in the broader context of ensuring food safety, upholding regulatory conformity, and facilitating the ethical application of veterinary drugs in animal agriculture. By quantifying MQCA levels, we actively contribute to the safeguarding of animal and human welfare, the preservation of consumer trust, and the promotion of sustainable and responsible agricultural practices within an increasingly complex and interconnected global food supply chain.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.